BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

992 related articles for article (PubMed ID: 26597426)

  • 1. Bisphosphocins: novel antimicrobials for enhanced killing of drug-resistant and biofilm-forming bacteria.
    Wong JP; DiTullio P; Parkinson S
    Future Microbiol; 2015; 10(11):1751-8. PubMed ID: 26597426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action.
    Roy R; Tiwari M; Donelli G; Tiwari V
    Virulence; 2018 Jan; 9(1):522-554. PubMed ID: 28362216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metal nanobullets for multidrug resistant bacteria and biofilms.
    Chen CW; Hsu CY; Lai SM; Syu WJ; Wang TY; Lai PS
    Adv Drug Deliv Rev; 2014 Nov; 78():88-104. PubMed ID: 25138828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-Activity Relationship of Amino Acid Tunable Lipidated Norspermidine Conjugates: Disrupting Biofilms with Potent Activity against Bacterial Persisters.
    Konai MM; Adhikary U; Samaddar S; Ghosh C; Haldar J
    Bioconjug Chem; 2015 Dec; 26(12):2442-53. PubMed ID: 26452096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane Active Small Molecules Show Selective Broad Spectrum Antibacterial Activity with No Detectable Resistance and Eradicate Biofilms.
    Hoque J; Konai MM; Gonuguntla S; Manjunath GB; Samaddar S; Yarlagadda V; Haldar J
    J Med Chem; 2015 Jul; 58(14):5486-500. PubMed ID: 26102297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial activities and action mechanism studies of transportan 10 and its analogues against multidrug-resistant bacteria.
    Xie J; Gou Y; Zhao Q; Li S; Zhang W; Song J; Mou L; Li J; Wang K; Zhang B; Yang W; Wang R
    J Pept Sci; 2015 Jul; 21(7):599-607. PubMed ID: 25891396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomaterials for alternative antibacterial therapy.
    Hemeg HA
    Int J Nanomedicine; 2017; 12():8211-8225. PubMed ID: 29184409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems?
    Smith AW
    Adv Drug Deliv Rev; 2005 Jul; 57(10):1539-50. PubMed ID: 15950314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tackling Threats and Future Problems of Multidrug-Resistant Bacteria.
    Medina E; Pieper DH
    Curr Top Microbiol Immunol; 2016; 398():3-33. PubMed ID: 27406189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial peptides and their interaction with biofilms of medically relevant bacteria.
    Batoni G; Maisetta G; Esin S
    Biochim Biophys Acta; 2016 May; 1858(5):1044-60. PubMed ID: 26525663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of bacterial biofilm on the treatment of prosthetic joint infections.
    Jacqueline C; Caillon J
    J Antimicrob Chemother; 2014 Sep; 69 Suppl 1():i37-40. PubMed ID: 25135088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the in vitro activity of novel lipoglycopeptide antibiotics.
    Arhin FF; Belley A; McKay GA; Moeck G
    Curr Protoc Microbiol; 2010 Feb; Chapter 17():Unit17.1. PubMed ID: 20131224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bactericidal, quorum quenching and anti-biofilm nanofactories: a new niche for nanotechnologists.
    Singh BN; Prateeksha ; Upreti DK; Singh BR; Defoirdt T; Gupta VK; De Souza AO; Singh HB; Barreira JC; Ferreira IC; Vahabi K
    Crit Rev Biotechnol; 2017 Jun; 37(4):525-540. PubMed ID: 27684212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of colistin combined with doripenem at clinically relevant concentrations against multidrug-resistant Pseudomonas aeruginosa in an in vitro dynamic biofilm model.
    Lora-Tamayo J; Murillo O; Bergen PJ; Nation RL; Poudyal A; Luo X; Yu HY; Ariza J; Li J
    J Antimicrob Chemother; 2014 Sep; 69(9):2434-42. PubMed ID: 24833752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents.
    Allahverdiyev AM; Kon KV; Abamor ES; Bagirova M; Rafailovich M
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1035-52. PubMed ID: 22029522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biofilm-associated infections: antibiotic resistance and novel therapeutic strategies.
    Sun F; Qu F; Ling Y; Mao P; Xia P; Chen H; Zhou D
    Future Microbiol; 2013 Jul; 8(7):877-86. PubMed ID: 23841634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agents that inhibit bacterial biofilm formation.
    Rabin N; Zheng Y; Opoku-Temeng C; Du Y; Bonsu E; Sintim HO
    Future Med Chem; 2015; 7(5):647-71. PubMed ID: 25921403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial resistance among aerobic biofilm producing bacteria isolated from chronic wounds in the tertiary care hospitals of Peshawar, Pakistan.
    Rahim K; Qasim M; Rahman H; Khan TA; Ahmad I; Khan N; Ullah A; Basit A; Saleha S
    J Wound Care; 2016 Aug; 25(8):480-6. PubMed ID: 27523661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Antibacterial Activity of Metal Complexes Containing 1,10- phenanthroline: Potential as Alternative Therapeutics in the Era of Antibiotic Resistance.
    Viganor L; Howe O; McCarron P; McCann M; Devereux M
    Curr Top Med Chem; 2017; 17(11):1280-1302. PubMed ID: 27697043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of gentamicin, vancomycin or amikacin combined with EDTA or l-arginine as lock therapy against a wide spectrum of biofilm-forming clinical strains isolated from catheter-related infections.
    Lebeaux D; Leflon-Guibout V; Ghigo JM; Beloin C
    J Antimicrob Chemother; 2015; 70(6):1704-12. PubMed ID: 25712314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.